Background The prevalence of opiate use among pregnant women can range from 1% to
2% to as high as 21%. Just in the United States alone, among pregnant women with hospital …

Background Several types of medications have been used for stabilizing heroin users:
Methadone, Buprenorphine and levo‐alpha‐acetyl‐methadol (LAAM.) The present review …

These Guidelinesreview the use of medicines such as methadone, buprenorphine,
naltrexone and clonidine in combination with psychosocial support in the treatment of …

The British Association for Psychopharmacology guidelines for the treatment of substance
abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on …

The unique pharmacology of buprenorphine at the mu-opioid receptor (ie high affinity, low
intrinsic activity and slow dissociation) results in buprenorphine having:(1) a good safety …

Aims To evaluate the efficacy and safety of methadone versus buprenorphine treatment in
pregnant opioid‐dependent women. Design Randomized, double‐dummy, double‐blind …

Aims. To evaluate the effectiveness of buprenorphine compared with methadone
maintenance therapy in opiate addicts over a treatment period of 24 weeks. Design …

It is estimated that 55–94% of infants born to opioid-dependent mothers in US will show
signs of opioid withdrawal. Buprenorphine has been reported to produce little or no …

Aims Through a novel synthesis of the literature and our own clinical experience, we have
derived a set of evidence‐based recommendations for consideration as guidance in the …

Aims: To assess the maternal and fetal acceptability of buprenorphine and neonatal
abstinence syndrome (NAS) in children born to buprenorphine‐maintained mothers. Design …